Chronic heart failure
351 results
150 - 249
Amyloidosis 
Non‐invasive positive pressure ventilation for central sleep apnoea in adults- HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis
SGLT2 inhibitors, GLP1 agonists provide greater benefit for patients with type 2 diabetes- SGLT-2 inhibitors and GLP-1 agonists for diabetes and chronic kidney disease
- In high-risk older patients with atrial fibrillation, rhythm control reduces cardiovascular death and stroke, but at a price
- Post-MI beta-blockers do not decrease mortality
- Aldosterone antagonists for people with chronic kidney disease requiring dialysis
- A patient with jaundice (icterus)
- Sodium‐glucose co‐transporter protein 2 (SGLT2) inhibitors for people with chronic kidney disease and diabetes
- Chronic diseases and pregnancy
- Dietary interventions for adults with chronic kidney disease
- Cardioselective beta‐blockers for chronic obstructive pulmonary disease
- Haemochromatosis
- Cardiac rehabilitation for people with heart disease: an overview of Cochrane systematic reviews
- Assessing a patient with an abnormal liver function test result
- Drugs for ventricular rate control in atrial fibrillation
- Oxygen therapy for dyspnoea in adults: Cochrane systematic review
- Acute kidney injury
- Increased pulmonary blood pressure: pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
- Systemic sclerosis
- Dronedarone in atrial fibrillation
- Cardioselective beta‐blockers for reversible airway disease
- Taking furosemide on day of surgery does not increase intraop hypotension
- Angiotensin receptor blockers for heart failure
- Phosphate binders for preventing and treating chronic kidney disease‐mineral and bone disorder (CKD‐MBD)
- Continuous infusion versus bolus injection of loop diuretics for acute heart failure
- Bolus loop diuretics = continuous infusion in treatment of CHF (DOSE trial)
- Greater continuity of care associated with fewer preventable hospitalizations
- Dyspnoea
- Excessive sweating (hyperhidrosis)
- Endovascular versus open surgical repair for complicated chronic Type B aortic dissection
- COVID-19 research briefs: case series of critically ill patients in the intensive care unit
- 2022 NICE guidance: type 2 diabetes
- Erythropoiesis‐stimulating agents for anaemia in adults with chronic kidney disease: a network meta‐analysis
- CV interventions in old elderly are not useful (DEBATE)
- Decreased hospital LOS not associated with increase in 30-day readmission rates
- Hyponatraemia
- Deep vein thrombosis
- Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease
- Treatment of acute hypoxemic respiratory failure with noninvasive ventilation using a helmet or face mask led to fewer deaths
- Chronic coronary syndrome (coronary heart disease)
- Anticoagulation versus placebo for heart failure in sinus rhythm
- CRP concentration in the diagnostics of lower respiratory infections
- Hyperkalaemia
- Dapagliflozin reduces mortality and renal replacement in patients with chronic kidney disease
- Hydralazine in infants with persistent hypoxemic respiratory failure: Cochrane systematic review
- mHealth education interventions in heart failure
- Dronedarone in the prevention of atrial fibrillation - Image
- Interleukin‐receptor antagonist and tumour necrosis factor inhibitors for the primary and secondary prevention of atherosclerotic cardiovascular diseases
- Prehospital emergency care
- Vitamin D for the management of chronic obstructive pulmonary disease
- Treatment with SGLT2 inhibitors rarely results in diabetic ketoacidosis
- SGLT-2 inhibitors in type 2 diabetes
- Preoperative assessment
- For patients with chronic kidney disease, prehydration prior to contrast-enhanced computed tomography is unnecessary
- Individualizing T2DM goals is paramount, according to experts
- Leg oedema
- Early treatment with ACE inhibitors in acute myocardial infarction
- Pregabalin for decreasing pancreatic pain in chronic pancreatitis: Cochrane systematic review
- ACC/AHA guidelines for the diagnosis and management of atrial fibrillation
- Safe use of non-steroidal anti-inflammatory drugs (NSAIDs)
- For severe hypoxemia due to chronic obstructive pulmonary disease or pulmonary fibrosis, 24 hours of oxygen is no better than 15 hours
- More evidence against antibiotics for acute asthma exacerbations
- Prolonged cough in adults
- Systemic lupus erythematosus (SLE)
- Higher hemoglobin target with epoeitin alfa is harmful in CKD (CHOIR)
- Methods of vascular occlusion for elective liver resections
- Hypertension: investigations, treatment initiation and non-pharmacological treatment
- Isolated diastolic hypertension not associated with increased risk of CVD
- No benefit to addition of stenting for treatment of atherosclerotic renal artery stenosis
- Treatment of chronic renal failure
- Antioxidants for adults with chronic kidney disease
- Short-term high-flow oxygen therapy for low-risk patients decreases reintubation rates
- Diabetic kidney disease (diabetic nephropathy)
- Mitral regurgitation
- Oral antidiabetic drugs and GLP-1 analogues
- JNC 8 report on prevention/evaluation/treatment of hypertension
- Interventions for chronic non‐hypovolaemic hypotonic hyponatraemia
- Trypanosomiases
- Riociguat for pulmonary hypertension
- ACC/AHA guideline for the management of patients with chronic coronary disease
- Adults with varicose veins are at increased risk of DVT
- In adults with medical comorbidities, influenza vaccinations are associated with a lower risk of developing dementia
- Cinnamon for diabetes mellitus
- Eosinophilic pneumonia
- Eplerenone for hypertension
- Glucagon‐like peptide 1 (GLP‐1) receptor agonists for people with chronic kidney disease and diabetes
- Rosuvastatin does not improve outcomes in HF with average lipids
- Recurrent infections and immunodeficiencies in children
- Assessment of ventricular hypertrophies from an ECG
- Insomnia